You Q - Search Results

1

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope.

Ma S, Ji J, Tong Y, Zhu Y, Dou J, Zhang X, Xu S, Zhu T, Xu X, You Q, Jiang Z. Ma S, et al. Among authors: you q. Acta Pharm Sin B. 2022 Jul;12(7):2990-3005. doi: 10.1016/j.apsb.2022.02.022. Epub 2022 Feb 26. Acta Pharm Sin B. 2022. PMID: 35865099 Free PMC article. Review.

2

Design, synthesis and bioevaluation of dihydropyrazolo[3,4-b]pyridine and benzo[4,5]imidazo[1,2-a]pyrimidine compounds as dual KSP and Aurora-A kinase inhibitors for anti-cancer agents.

Fu RG, You QD, Yang L, Wu WT, Jiang C, Xu XL. Fu RG, et al. Bioorg Med Chem. 2010 Nov 15;18(22):8035-43. doi: 10.1016/j.bmc.2010.09.020. Epub 2010 Sep 16. Bioorg Med Chem. 2010. PMID: 20934346

3

Synthesis and evaluation of novel aza-caged Garcinia xanthones.

Zhang X, Li X, Sun H, Jiang Z, Tao L, Gao Y, Guo Q, You Q. Zhang X, et al. Among authors: you q. Org Biomol Chem. 2012 Apr 28;10(16):3288-99. doi: 10.1039/c2ob07088j. Epub 2012 Mar 12. Org Biomol Chem. 2012. PMID: 22407464

4

Synthesis, SAR and biological evaluation of natural and non-natural hydroxylated and prenylated xanthones as antitumor agents.

Zhang X, Li X, Ye S, Zhang Y, Tao L, Gao Y, Gong D, Xi M, Meng H, Zhang M, Gao W, Xu X, Guo Q, You Q. Zhang X, et al. Among authors: you q. Med Chem. 2012 Nov;8(6):1012-25. doi: 10.2174/1573406411208061012. Med Chem. 2012. PMID: 22779801

5

Novel IKKβ inhibitors discovery based on the co-crystal structure by using binding-conformation-based and ligand-based method.

Huang JJ, Wu XW, Jia JM, Guo XK, Xue X, Jiang ZY, Zhang SL, Zhang XJ, Sun HP, You QD. Huang JJ, et al. Eur J Med Chem. 2013 May;63:269-78. doi: 10.1016/j.ejmech.2013.01.045. Epub 2013 Feb 17. Eur J Med Chem. 2013. PMID: 23501112

6

Identification, design and bio-evaluation of novel Hsp90 inhibitors by ligand-based virtual screening.

Jia J, Xu X, Liu F, Guo X, Zhang M, Lu M, Xu L, Wei J, Zhu J, Zhang S, Zhang S, Sun H, You Q. Jia J, et al. Among authors: you q. PLoS One. 2013;8(4):e59315. doi: 10.1371/journal.pone.0059315. Epub 2013 Apr 2. PLoS One. 2013. PMID: 23565147 Free PMC article.

7

Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.

Zhou Y, Xu X, Sun Y, Wang H, Sun H, You Q. Zhou Y, et al. Among authors: you q. Bioorg Med Chem Lett. 2013 May 15;23(10):2974-8. doi: 10.1016/j.bmcl.2013.03.037. Epub 2013 Mar 20. Bioorg Med Chem Lett. 2013. PMID: 23566520

8

Synthesis and bioevaluation of a series of α-pyrone derivatives as potent activators of Nrf2/ARE pathway (part I).

Xi MY, Sun ZY, Sun HP, Jia JM, Jiang ZY, Tao L, Ye M, Yang X, Wang YJ, Xue X, Huang JJ, Gao Y, Guo XK, Zhang SL, Yang YR, Guo QL, Hu R, You QD. Xi MY, et al. Eur J Med Chem. 2013 Aug;66:364-71. doi: 10.1016/j.ejmech.2013.06.007. Epub 2013 Jun 14. Eur J Med Chem. 2013. PMID: 23820128

9

Indenoisoquinoline derivatives as topoisomerase I inhibitors that suppress angiogenesis by affecting the HIF signaling pathway.

Xu X, Liu F, Zhang S, Jia J, Li Z, Guo X, Yang Y, Sun H, You Q. Xu X, et al. Among authors: you q. Biomed Pharmacother. 2013 Oct;67(8):715-22. doi: 10.1016/j.biopha.2013.06.004. Epub 2013 Jul 4. Biomed Pharmacother. 2013. PMID: 23932721

10

Discovery and design of tricyclic scaffolds as protein kinase CK2 (CK2) inhibitors through a combination of shape-based virtual screening and structure-based molecular modification.

Sun H, Xu X, Wu X, Zhang X, Liu F, Jia J, Guo X, Huang J, Jiang Z, Feng T, Chu H, Zhou Y, Zhang S, Liu Z, You Q. Sun H, et al. Among authors: you q. J Chem Inf Model. 2013 Aug 26;53(8):2093-102. doi: 10.1021/ci400114f. Epub 2013 Aug 12. J Chem Inf Model. 2013. PMID: 23937544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,512 results

Search Page